43882 Federal Register / Vol. 83, No. 167 / Tuesday, August 28, 2018 / Notices 

using the bulk drug substance 

vasopressin and, therefore, we propose 

to not include vasopressin on the 503B 

Bulks List. 

Dated: August 23, 2018. 

Leslie Kux, 

Associate Commissioner for Policy. 

[FR Doc. 2018–18614 Filed 8–27–18; 8:45 am] 

BILLING CODE 4164–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Office of the Secretary 

Notice of Interest Rate on Overdue 

Debts 

Section 30.18 of the Department of 

Health and Human Services’ claims 

collection regulations (45 CFR part 30) 

provides that the Secretary shall charge 

an annual rate of interest, which is 

determined and fixed by the Secretary 

of the Treasury after considering private 

consumer rates of interest on the date 

that the Department of Health and 

Human Services becomes entitled to 

recovery. The rate cannot be lower than 

the Department of Treasury’s current 

value of funds rate or the applicable rate 

determined from the ‘‘Schedule of 

Certified Interest Rates with Range of 

Maturities’’ unless the Secretary waives 

interest in whole or part, or a different 

rate is prescribed by statute, contract, or 

repayment agreement. The Secretary of 

the Treasury may revise this rate 

quarterly. The Department of Health and 

Human Services publishes this rate in 

the Federal Register. 

The current rate of 101⁄4%, as fixed by 

the Secretary of the Treasury, is certified 

for the quarter ended June 30, 2018. 

This rate is based on the Interest Rates 

for Specific Legislation, ‘‘National 

Health Services Corps Scholarship 

Program (42 U.S.C. 254o(b)(1)(A))’’ and 

‘‘National Research Service Award 

Program (42 U.S.C. 288(c)(4)(B)).’’ This 

interest rate will be applied to overdue 

debt until the Department of Health and 

Human Services publishes a revision. 

Dated: August 23, 2018. 

David C. Horn, 

Director, Office of Financial Policy and 

Reporting. 

[FR Doc. 2018–18648 Filed 8–27–18; 8:45 am] 

BILLING CODE 4150–04–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

[Document Identifier: OS–0990—New] 

Agency Information Collection 

Request. 60-Day Public Comment 

Request 

AGENCY: Office of the Secretary, HHS. 

ACTION: Notice. 

SUMMARY: In compliance with the 

requirement of the Paperwork 

Reduction Act of 1995, the Office of the 

Secretary (OS), Department of Health 

and Human Services, is publishing the 

following summary of a proposed 

collection for public comment. 

DATES: Comments on the ICR must be 

received on or before October 29, 2018. 

ADDRESSES: Submit your comments to 

Sherrette.Funn@hhs.gov or by calling 

(202) 795–7714. 

FOR FURTHER INFORMATION CONTACT: 

When submitting comments or 

requesting information, please include 

the document identifier 0990–New— 

60D and project title for reference., to 

Sherrette.funn@hhs.gov, or call 202– 

795–7714, Sherrette Funn, the Reports 

Clearance Officer. 

SUPPLEMENTARY INFORMATION: Interested 

persons are invited to send comments 

regarding this burden estimate or any 

other aspect of this collection of 

information, including any of the 

following subjects: (1) The necessity and 

utility of the proposed information 

collection for the proper performance of 

the agency’s functions; (2) the accuracy 

of the estimated burden; (3) ways to 

enhance the quality, utility, and clarity 

of the information to be collected; and 

(4) the use of automated collection 

techniques or other forms of information 

technology to minimize the information 

collection burden. 

Title of the Collection: Cross-Site 

Evaluation on the Women’s Health 

College Sexual Assault Policy and 

Prevention Initiative. 

Type of Collection: New. 

OMB No. 0990–XXXX: Office of 

Women’s Health within OS. 

Abstract: The Office of Women’s 

Health is seeking an approval by OMB 

on a new information collection, CrossSite Evaluation on the Women’s Health 

College Sexual Assault. The purpose of 

this data collection is to gather 

qualitative data across the nine grantee 

organizations and partners via 

interviews to gain a full understanding 

of grantee and partner perceived success 

over the course of the three-year project; 

grantee and partner experiences with 

the initiative; barriers and facilitators to 

project implementation; sustainability 

of grantee efforts; and anecdotal or other 

evidence of reductions in campus 

sexual violence. Interviews conducted 

with individuals representing the 

grantee organizations and campus 

partners, and will occur once per 

respondent in the spring of 2019. 

The CDC estimates that 23 million 

women have experienced completed or 

attempted rape in their lifetimes. 

(National Intimate Partner and Sexual 

Violence Survey, https://www.cdc.gov/ 

mmwr/preview/mmwrhtml/ 

ss6308a1.htm). A September 2015 

Association of American Universities 

(AAU) survey of 150,000 students across 

27 colleges and universities indicated 

that 23% of female undergraduate 

students reported experiencing sexual 

assault since enrolling in college (AAU 

Campus Climate Survey on Sexual 

Assault and Sexual Misconduct, https:// 

www.aau.edu/sites/default/files/ 

%40%20Files/Climate%20Survey/ 

Executive%20Summary%2012-14- 

15.pdf). 

The College Sexual Assault Policy, 

and Prevention Initiative of the 

Department of Health and Human 

Services, Office of Women’s Health, has 

three main goals: (1) Disseminate sexual 

assault policy and prevention 

information to organizations in a 

position to influence and implement 

policies and practices at post-secondary 

schools; (2) provide technical assistance 

to post-secondary schools to establish 

policies and practices that prevent 

sexual assault; and (3) assess the success 

of policy establishment and sustained 

prevention strategies enacted by 

partnering organizations and postsecondary schools. 


daltland on DSKBBV9HB2PROD with NOTICES
Federal Register / Vol. 83, No. 167 / Tuesday, August 28, 2018 / Notices 43883 

ANNUALIZED BURDEN HOUR TABLE

Forms Respondents Number of 

respondents 

Number of 

responses per 

respondents 

Average 

burden per 

response 

(within hours) 

Total burden 

hours 

Grantee key informant interview 

guides.

Grantee organization representative 9 1 1 9 

Partner campus key informant interview guides.Partner campus representative ........ 36 1 1 36 

Total ........................................... ........................................................... ........................ ........................ ........................ 45 

Terry Clark, 

Asst Reduction Act Reports Clearance Officer, 

Office of the Secretary. 

[FR Doc. 2018–18544 Filed 8–27–18; 8:45 am] 

BILLING CODE 4150–33–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Center for Complementary & 

Integrative Health; Notice of Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the National Advisory 

Council for Complementary and 

Integrative Health. 

The meeting will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Advisory 

Council for Complementary and Integrative 

Health. 

Date: October 5, 2018. 

Closed: 8:30 a.m. to 9:45 a.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Building 31, Conference Room 10, 31 Center 

Drive, Bethesda, MD 20892. 

Open: 10:00 a.m. to 4:00 p.m. 

Agenda: A report from the Institute 

Director and other staff. 

Place: National Institutes of Health, 

Building 31, Conference Room 10, 31 Center 

Drive, Bethesda, MD 20892. 

Contact Person: Partap Singh Khalsa, 

Ph.D., DC, Director, Division of Extramural 

Activities, National Center for 

Complementary and Integrative Health, NIH, 

National Institutes of Health, 6707 

Democracy Blvd., Ste. 401, Bethesda, MD 

20892–5475, (301) 594–3462, khalsap@

mail.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

form of identification (for example, a 

government-issued photo ID, driver’s license, 

or passport) and to state the purpose of their 

visit. 

Information is also available on the 

Institute’s/Center’s home page: https://

nccih.nih.gov/about/naccih/, where an 

agenda and any additional information for 

the meeting will be posted when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.213, Research and Training 

in Complementary and Integrative Health, 

National Institutes of Health, HHS) 

Dated: August 22, 2018. 

David D. Clary, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2018–18548 Filed 8–27–18; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Heart, Lung, and Blood 

Institute Notice of Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the Sickle Cell Disease 

Advisory Committee. 

The meeting will be open to the 

public, with attendance limited to space 

available. Individuals who plan to 

attend and need special assistance, such 

as sign language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

Name of Committee: Sickle Cell Disease 

Advisory Committee. 

Date: November 16, 2018. 

Time: 8:30 a.m. to 4:00 p.m. 

Agenda: Presentations and Discussion of 

Programs. 

Place: National Heart, Lung, and Blood 

Institute, 6701 Rockledge Drive, 9th Floor, 

Room 9100/9104, Bethesda, MD 20892. 

Contact Person: W. Keith Hoots, MD, 

Director, Division of Blood Diseases and 

Resources, National Heart, Lung, and Blood 

Institute, 6701 Rockledge Drive, Suite 9030, 

Bethesda, MD 20892, 301–435–0080, 

hootswk@nhlbi.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.233, National Center for 

Sleep Disorders Research; 93.837, Heart and 

Vascular Diseases Research; 93.838, Lung 

Diseases Research; 93.839, Blood Diseases 

and Resources Research, National Institutes 

of Health, HHS) 

Dated: August 22, 2018. 

David D. Clary, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2018–18549 Filed 8–27–18; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of a meeting of the 

National Cancer Institute Clinical Trials 

and Translational Research Advisory 

Committee. 

The meeting will be open to the 

public, with attendance limited to space 

available. Individuals who plan to 

attend and need special assistance, such 


daltland on DSKBBV9HB2PROD with NOTICES